Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.60K | 17.60K | 17.60K | 35.20K | -- |
| Total Receivables | 86.00K | 124.40K | 89.80K | 69.20K | 64.50K |
| Inventory | 17.10K | 23.80K | 18.60K | 19.50K | 74.10K |
| Prepaid Expenses | 30.00K | 34.00K | 34.00K | 30.00K | 30.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 160.10K | 160.10K | 160.10K | 160.10K | 195.30K |
| Total Current Assets | 310.80K | 359.90K | 320.10K | 314.10K | 363.80K |
|
|
|||||
| Total Current Assets | 310.80K | 359.90K | 320.10K | 314.10K | 363.80K |
| Net Property, Plant & Equipment | 124.60K | 147.60K | 170.20K | 192.40K | 258.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 123.50K | 123.50K | 130.50K | 134.00K | 89.40K |
| Total Assets | 558.80K | 631.00K | 620.70K | 640.40K | 711.30K |
|
|
|||||
| Total Accounts Payable | 842.70K | 870.40K | 826.80K | 763.00K | 752.50K |
| Total Accrued Expenses | 3.16M | 3.01M | 2.85M | 2.76M | 3.32M |
| Short-term Debt | 3.38M | 3.29M | 3.13M | 2.75M | 2.63M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.16M | 6.23M | 6.20M | 6.32M | 6.24M |
| Total Finance Division Other Current Liabilities | 1.67M | 1.61M | 1.59M | 1.57M | 1.00M |
| Total Other Current Liabilities | 1.67M | 1.61M | 1.59M | 1.57M | 1.00M |
| Total Current Liabilities | 15.21M | 15.00M | 14.60M | 14.17M | 13.95M |
|
|
|||||
| Total Current Liabilities | 15.21M | 15.00M | 14.60M | 14.17M | 13.95M |
| Long-Term Debt | 141.10K | 142.00K | 142.80K | 143.70K | 171.00K |
| Short-term Debt | 3.38M | 3.29M | 3.13M | 2.75M | 2.63M |
| Capital Leases | 24.10K | 47.60K | 70.80K | 93.40K | 115.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.38M | 15.19M | 14.81M | 14.41M | 14.24M |
|
|
|||||
| Common Stock & APIC | 60.70M | 60.70M | 60.70M | 60.70M | 60.70M |
| Retained Earnings | -76.00M | -75.74M | -75.37M | -74.95M | -74.70M |
| Treasury Stock & Other | 469.70K | 469.70K | 473.20K | 469.70K | 469.70K |
| Total Common Equity | -14.83M | -14.57M | -14.20M | -13.78M | -13.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K |
|
|
|||||
| Total Common Equity | -14.83M | -14.57M | -14.20M | -13.78M | -13.54M |
| Total Preferred Equity | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.82M | -14.56M | -14.19M | -13.77M | -13.53M |
|
|
|||||